Bernhard H - Search Results

1

CTLs directed against HER2 specifically cross-react with HER3 and HER4.

Conrad H, Gebhard K, Krönig H, Neudorfer J, Busch DH, Peschel C, Bernhard H. Conrad H, et al. Among authors: bernhard h. J Immunol. 2008 Jun 15;180(12):8135-45. doi: 10.4049/jimmunol.180.12.8135. J Immunol. 2008. PMID: 18523278 Free article.

2

Infection of human dendritic cells with recombinant vaccinia virus MVA reveals general persistence of viral early transcription but distinct maturation-dependent cytopathogenicity.

Kastenmuller W, Drexler I, Ludwig H, Erfle V, Peschel C, Bernhard H, Sutter G. Kastenmuller W, et al. Among authors: bernhard h. Virology. 2006 Jul 5;350(2):276-88. doi: 10.1016/j.virol.2006.02.039. Epub 2006 Apr 3. Virology. 2006. PMID: 16595141 Free article.

3

Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6.

Witzens-Harig M, Hose D, Jünger S, Pfirschke C, Khandelwal N, Umansky L, Seckinger A, Conrad H, Brackertz B, Rème T, Gueckel B, Meißner T, Hundemer M, Ho AD, Rossi JF, Neben K, Bernhard H, Goldschmidt H, Klein B, Beckhove P. Witzens-Harig M, et al. Among authors: bernhard h. Blood. 2013 May 30;121(22):4493-503. doi: 10.1182/blood-2012-05-429415. Epub 2013 Apr 19. Blood. 2013. PMID: 23603913 Free article.

4

The efficiency of human cytomegalovirus pp65(495-503) CD8+ T cell epitope generation is determined by the balanced activities of cytosolic and endoplasmic reticulum-resident peptidases.

Urban S, Textoris-Taube K, Reimann B, Janek K, Dannenberg T, Ebstein F, Seifert C, Zhao F, Kessler JH, Halenius A, Henklein P, Paschke J, Cadel S, Bernhard H, Ossendorp F, Foulon T, Schadendorf D, Paschen A, Seifert U. Urban S, et al. Among authors: bernhard h. J Immunol. 2012 Jul 15;189(2):529-38. doi: 10.4049/jimmunol.1101886. Epub 2012 Jun 15. J Immunol. 2012. PMID: 22706083 Free article.

5

NY-ESO-1 antigen-reactive T cell receptors exhibit diverse therapeutic capability.

Sommermeyer D, Conrad H, Krönig H, Gelfort H, Bernhard H, Uckert W. Sommermeyer D, et al. Among authors: bernhard h. Int J Cancer. 2013 Mar 15;132(6):1360-7. doi: 10.1002/ijc.27792. Epub 2012 Sep 14. Int J Cancer. 2013. PMID: 22907642 Free PMC article.

6

Allorestricted T lymphocytes with a high avidity T-cell receptor towards NY-ESO-1 have potent anti-tumor activity.

Krönig H, Hofer K, Conrad H, Guilaume P, Müller J, Schiemann M, Lennerz V, Cosma A, Peschel C, Busch DH, Romero P, Bernhard H. Krönig H, et al. Among authors: bernhard h. Int J Cancer. 2009 Aug 1;125(3):649-55. doi: 10.1002/ijc.24414. Int J Cancer. 2009. PMID: 19444908 Free article.

7

Visualization of antigen-specific human cytotoxic T lymphocytes labeled with superparamagnetic iron-oxide particles.

Beer AJ, Holzapfel K, Neudorfer J, Piontek G, Settles M, Krönig H, Peschel C, Schlegel J, Rummeny EJ, Bernhard H. Beer AJ, et al. Among authors: bernhard h. Eur Radiol. 2008 Jun;18(6):1087-95. doi: 10.1007/s00330-008-0874-4. Epub 2008 Feb 20. Eur Radiol. 2008. PMID: 18286290

8

The immunogenicity of Bcr-Abl expressing dendritic cells is dependent on the Bcr-Abl kinase activity and dominated by Bcr-Abl regulated antigens.

Scheich F, Duyster J, Peschel C, Bernhard H. Scheich F, et al. Among authors: bernhard h. Blood. 2007 Oct 1;110(7):2556-60. doi: 10.1182/blood-2007-01-071001. Epub 2007 Jun 19. Blood. 2007. PMID: 17579186 Free article.

9

Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens.

Neudorfer J, Schmidt B, Huster KM, Anderl F, Schiemann M, Holzapfel G, Schmidt T, Germeroth L, Wagner H, Peschel C, Busch DH, Bernhard H. Neudorfer J, et al. Among authors: bernhard h. J Immunol Methods. 2007 Mar 30;320(1-2):119-31. doi: 10.1016/j.jim.2007.01.001. Epub 2007 Jan 31. J Immunol Methods. 2007. PMID: 17306825

10

Isolation and expansion of tumor-reactive cytotoxic T-cell clones for adoptive immunotherapy.

Bernhard H, Schmidt B, Busch DH, Peschel C. Bernhard H, et al. Methods Mol Med. 2005;109:175-84. doi: 10.1385/1-59259-862-5:175. Methods Mol Med. 2005. PMID: 15585921

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results